Eventhum Orthopaedics Secures £3.8M to Innovate Surgery
Transforming Orthopaedic Surgery: Eventhum Orthopaedics Secures £3.8M Funding
In an exhilarating stride towards revolutionizing knee replacement procedures, Eventhum Orthopaedics, a medtech innovator based in Leeds, UK, has recently secured an impressive £3.8 million in funding. This substantial investment round, led by NPIF II – Mercia Equity Finance alongside Mercia's EIS funds and several private investors, underscores the growing confidence in this pioneering organization's potential to reshape surgical practices. With an extraordinary edge in orthopaedic technology, Eventhum is poised to alter the landscape of knee surgery.
At the heart of Eventhum's innovations is the QuadSense device, designed to aid surgeons during total knee replacement surgeries by ensuring precise cuts and accurate kneecap placements.
Having already received regulatory approvals in both the UK and US, the QuadSense device has been utilized in over 300 successful procedures, elevating surgical proficiency to unprecedented levels. With the funds from this latest round, Eventhum aims to bolster its product stock in the UK, US, and New Zealand while also pursuing the development of two additional devices aimed at enhancing shoulder and hip surgeries.
Under the leadership of CEO and Founder John Naybour, Eventhum is not just stopping at knee replacements. The company has ambitious plans to appoint distributors in numerous key international markets, a strategic move that aligns with its vision of transforming global orthopaedic care. With this latest round of funding bringing the total investments raised by the company to over £7 million, Eventhum Orthopaedics stands at the forefront of a medical revolution, appealing to both investors and stakeholders eager to support groundbreaking solutions in the healthcare sector.
Key Terms Explained
- Funding
- The money provided by investors or organizations to support a startup venture. In this case, Eventhum Orthopaedics secured £3.8 million.
- QuadSense device
- A key innovation of Eventhum, a device meant to improve precision in knee replacement surgery by assisting with accurate cuts and kneecap placements.
- Regulatory Approvals
- The official approval by regulatory bodies in a given market, here the UK and US, which allows a company to market and sell its products.
Frequently Asked Questions
- Who recently led the funding round for Eventhum Orthopaedics?-The recent funding round of £3.8 million for Eventhum Orthopaedics was led by NPIF II – Mercia Equity Finance.
- What is the total amount of investment raised by Eventhum Orthopaedics to date?+
- What is the primary function of the QuadSense device created by Eventhum?+
- What are the plans for Eventhum following its recent funding round?+
- Under whose leadership is Eventhum Orthopaedics operating?+
They've invested in Eventum Orthopaedics
Get to know these Healthtech investors
Click here for a full list of 7,233+ startup investors in the UK